Hemolytic Uremic Syndrome (HUS) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Na ïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Intervention: Biological: ALXN1210 Sponsor: Alexion Pharmaceuticals Not yet recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2016 Category: Research Source Type: clinical trials
